Faculty Opinions recommendation of Efficacy and safety of oral methazolamide in patients with type 2 diabetes: a 24-week, placebo-controlled, double-blind study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718533941.793499041 ◽

2014 ◽

Author(s):

Frank Greenway

Keyword(s):

Type 2 Diabetes ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Download Full-text

Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4): A 26-week double-blind study

Diabetes Care ◽

10.2337/dc11-1107 ◽

2011 ◽

Vol 35 (2) ◽

pp. 252-258 ◽

Author(s):

D. Russell-Jones ◽

R. M. Cuddihy ◽

M. Hanefeld ◽

A. Kumar ◽

J. G. Gonzalez ◽

...

Keyword(s):

Type 2 Diabetes ◽

Diabetes Duration ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Double Blind ◽

Download Full-text

Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a multi-centre, randomized, placebo-controlled, double-blind study

Diabetes Obesity and Metabolism ◽

10.1111/dom.12745 ◽

2016 ◽

Vol 18 (12) ◽

pp. 1207-1216 ◽

Author(s):

Hisamitsu Ishihara ◽

Susumu Yamaguchi ◽

Ikko Nakao ◽

Akira Okitsu ◽

Seitaro Asahina

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Japanese Patients ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Download Full-text

Efficacy and Safety of Oral Methazolamide in Patients With Type 2 Diabetes: A 24-Week, Placebo-Controlled, Double-Blind Study: Table 1

Diabetes Care ◽

10.2337/dc14-1038 ◽

2014 ◽

Vol 37 (11) ◽

pp. 3121-3123 ◽

Author(s):

Richard W. Simpson ◽

Geoffrey C. Nicholson ◽

Joseph Proietto ◽

Alana Sarah ◽

Kerrie M. Sanders ◽

...

Keyword(s):

Type 2 Diabetes ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Download Full-text

Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active‐controlled, randomized, double‐blind study with open‐label extension (the EVERGREEN study)

Diabetes Obesity and Metabolism ◽

10.1111/dom.14061 ◽

2020 ◽

Vol 22 (9) ◽

pp. 1527-1536

Author(s):

Gyuri Kim ◽

Soo Lim ◽

Hyuk‐Sang Kwon ◽

Ie B. Park ◽

Kyu J. Ahn ◽

...

Keyword(s):

Type 2 Diabetes ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Double Blind ◽

Open Label Extension

Download Full-text

Efficacy and safety of teneligliptin in Indian patients with inadequately controlled Type 2 diabetes mellitus: A randomized, double-blind study

Indian Journal of Endocrinology and Metabolism ◽

10.4103/ijem.ijem_97_16 ◽

2018 ◽

Vol 22 (1) ◽

pp. 41 ◽

Author(s):

Piyush Agarwal ◽

Chhavi Jindal ◽

Vinayak Sapakal

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Double Blind ◽

Indian Patients

Download Full-text

Efficacy and safety of sitagliptin/metformin fixed-dose combination compared with glimepiride in patients with type 2 diabetes: A multicenter randomized double-blind study

Journal of Diabetes ◽

10.1111/1753-0407.12432 ◽

2016 ◽

Vol 9 (4) ◽

pp. 412-422 ◽

Author(s):

Sang Soo Kim ◽

In Joo Kim ◽

Kwang Jae Lee ◽

Jeong Hyun Park ◽

Young Il Kim ◽

...

Keyword(s):

Type 2 Diabetes ◽

Blind Study ◽

Fixed Dose Combination ◽

Double Blind Study ◽

Efficacy And Safety ◽

Double Blind ◽

Dose Combination

Download Full-text

Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design

Diabetes Therapy ◽

10.1007/s13300-020-00924-9 ◽

2020 ◽

Vol 11 (11) ◽

pp. 2739-2755

Author(s):

Shinya Fujiki ◽

◽

Kenichi Iijima ◽

Masaaki Okabe ◽

Shinichi Niwano ◽

...

Keyword(s):

Type 2 Diabetes ◽

Implantable Cardioverter Defibrillator ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Cardioverter Defibrillator

Download Full-text

Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6)

Diabetes Obesity and Metabolism ◽

10.1111/dom.12009 ◽

2012 ◽

Vol 15 (3) ◽

pp. 234-240 ◽

Author(s):

R. E. Pratley ◽

D. Urosevic ◽

M. Boldrin ◽

R. Balena ◽

Keyword(s):

Type 2 Diabetes ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Metformin Therapy

Download Full-text

The effects of LY2189265, a long-acting glucagon-like peptide-1 analogue, in a randomized, placebo-controlled, double-blind study of overweight/obese patients with type 2 diabetes: the EGO study

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2011.01366.x ◽

2011 ◽

Vol 13 (5) ◽

pp. 418-425 ◽

Author(s):

G. E. Umpierrez ◽

T. Blevins ◽

J. Rosenstock ◽

C. Cheng ◽

J. H. Anderson ◽

...

Keyword(s):

Type 2 Diabetes ◽

Blind Study ◽

Double Blind Study ◽

Obese Patients ◽

Double Blind ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Download Full-text

Linagliptin monotherapy provides superior glycaemic control versus placebo or voglibose with comparable safety in Japanese patients with type 2 diabetes: a randomized, placebo and active comparator-controlled, double-blind study

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2011.01545.x ◽

2012 ◽

Vol 14 (4) ◽

pp. 348-357 ◽

Author(s):

R. Kawamori ◽

N. Inagaki ◽

E. Araki ◽

H. Watada ◽

N. Hayashi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Japanese Patients ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Active Comparator ◽

Download Full-text